drugset / Trial / NCT04073134
The CHORAL Flow Study
RandomizedParallel-groupQuadruple-blindTreatment
Summary
CHORAL Flow is a randomised, double blinded, placebo-controlled trial of the effects of evolocumab on coronary flow at 12 weeks.
Timeline
- Start
- 2019-09-11
- Primary completion
- 2022-03-27
- Completion
- 2022-05-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Evolocumab | Monoclonal antibody | 140 mg | Subcutaneous |